5INITIO Trial International Co-ordinating Committee, Yeni P, Cooper DA,et al. Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nu- eleoside reverse transeriptase inhibitor, protease inhibitor, or both in INIT10 :open-label randomised trial. Laneet,2006,368(9532) : 287 -298.
6Nelson M, Yau S, Baber L, et al. Combination antiretroviral therapy toxicities: a comparison between patients and health care professionals. J Acquir Immune Defic Syndr,2011,56(4) : 120-121.
7Anastasi JK, Capili B. Nausea and vomiting in HIV/AIDS. Gastroenterol Nurs ,2011,34 ( 1 ) : 15-24.
3Hoshino Y,Hoshino S,Nakata K,et al.Maximal HIV-1 replication in alvaolar macrophages during tuberculosis requires both lymphocyte contact and cytokines[J].Exp Med,2002,195(5):495-525.
4Zunda A,Malon P,Henderson J,et al.Impact of HIV infection On tuberculosis[J].Postgrad Med J,2000,76(895):259-268.
